Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Income from Continuing Operations (2022 - 2025)

Bioregenx (BRGX) has 4 years of Income from Continuing Operations data on record, last reported at 80565.0 in Q3 2025.

  • For Q3 2025, Income from Continuing Operations rose 79.6% year-over-year to 80565.0; the TTM value through Sep 2025 reached 18926335.0, down 294.89%, while the annual FY2024 figure was 23054017.0, 3216.31% down from the prior year.
  • Income from Continuing Operations reached 80565.0 in Q3 2025 per BRGX's latest filing, up from 178345.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 2191.0 in Q3 2022 and bottomed at 18400571.0 in Q4 2024.
  • Average Income from Continuing Operations over 4 years is 1623550.67, with a median of 139319.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: crashed 26695.74% in 2024, then soared 91.54% in 2025.
  • A 4-year view of Income from Continuing Operations shows it stood at 5535.0 in 2022, then plummeted by 2417.06% to 139319.0 in 2023, then crashed by 13107.51% to 18400571.0 in 2024, then skyrocketed by 99.56% to 80565.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 80565.0 in Q3 2025, 178345.0 in Q2 2025, and 266854.0 in Q1 2025.